Jane Street Group, LLC Precision Biosciences Inc Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.7 - $1.41 $44,508 - $89,653	-63,584 Reduced 75.48%	20,654 $15,000
Q4 2022 Feb 14, 2023	BUY	$0.97 - $45.0 $63,973 - $2.97 Million	65,952 Added 360.67%	84,238 $100,000
Q3 2022 Nov 14, 2022	BUY	$1.22 - $40.8 $22,308 - $746,068	18,286 New	18,286 $24,000
Q2 2022 Aug 16, 2022	SELL	$1.15 - $3.34 $16,119 - $46,816	-14,017 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$2.96 - $7.76 $41,490 - $108,771	14,017 New	14,017 $43,000
Q4 2021 Feb 15, 2022	SELL	$7.4 - $11.66 $189,928 - $299,265	-25,666 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$9.18 - $14.15 $251,541 - $387,724	-27,401 Reduced 51.63%	25,666 $296,000
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $428,250 - $664,398	53,067 New	53,067 $665,000
Q1 2021 May 18, 2021	SELL	$8.57 - $15.79 $254,923 - $469,689	-29,746 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$5.98 - $12.47 $177,881 - $370,932	29,746 New	29,746 $249,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $802M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.